基酸通过Pit-1减少高酸血症诱导的血管化
Hualong Zang1,2, Yang Liu1,2, Qiuping Teng1,2
1Nephrology Department, Jingmen Central Hospital Affiliated to Hubei Minzu University, Jingmen, Hubei, China.
高酸盐水平会通过上调酸盐携带载体-1 (Pit-1) 来引起血管化. 用基酸 (PFA) 抑制Pit-1可以治疗这种情况,但需要进一步的临床试验.
科学领域:
- 心血管生物学 心血管生物学
- 脏生理学 脏生理学
- 血管生物学 血管生物学
背景情况:
- 过酸血是慢性病的一个常见并发症.
- 血管化与心血管发病率和死亡率的增加有关.
- 将高酸血症与血管化联系在一起的精确机制需要进一步阐明.
研究的目的:
- 为了研究酸盐携带载体-1 (Pit-1) 在高酸血症诱导的血管化 (HPVC) 中的作用.
- 探索Pit-1抑制作为HPVC治疗策略的潜力.
主要方法:
- 主要的人类大动脉光滑肌细胞和老鼠大动脉环在不同度下培养.
- 评估了使用小干扰RNA和基酸 (PFA) 抑制Pit-1的影响.
- 分析了阿利沙林红色染色,Pit-1表达和光滑肌肉细胞表型标记.
主要成果:
- 过光血症上调了Pit-1表达,并诱导了血管光滑肌肉细胞的表型过渡,导致HPVC.
- 通过siRNA或PFA抑制Pit-1,显著降低了Pit-1的表达,并减弱了HPVC.
- 这些发现在细胞和器官模型中是一致的.
结论:
- 皮特-1是HPVC病变发生的关键媒介.
- 基酸 (PFA) 通过抑制Pit-1来显示HPVC的治疗潜力.
- 需要进一步的临床研究来验证PFA在患者中的安全性和有效性.
更多相关视频
14:55Analysis of Minerals Produced by hFOB 1.19 and Saos-2 Cells Using Transmission Electron Microscopy with Energy Dispersive X-ray Microanalysis
Published on: June 24, 2018
08:43Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
相关概念视频
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
IP3/DAG Signaling Pathway
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
The JAK-STAT Signaling Pathway
